DENESIA GIFFIN: Open Payments
NPI 1568490241 · VICKSBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 28 payments from 12 companies in 2025. Trend: 2023 $613 · 2024 $381 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $229 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Novo Nordisk Inc | 5 | $80 |
| Stryker Corporation | 1 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| SANOFI PASTEUR INC. | 1 | $28 |
| PFIZER INC. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: Veozah, BREZTRI, Wegovy, CLOTTRIEVER BOLD CATHETER, VOQUEZNA, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, PREVNAR 20, INSPIRE.
Industry payments across MS — which companies pay providers there.
